ISPE

OCTOBER 1, 2023

Reveal the hidden challenges, opportunities, and trends impacting validation and quality professionals like you, with the world's first annual validation industry survey and report—the State of Validation. What the biggest challenges impacting validation professionals are. How other companies are adopting validation technologies.

Communication 52

Communication 52

The Thyroid Pharmacist

JULY 20, 2023

I was tested for anemia, but not “anemic” (per the usual tests), and eventually I learned that beyond the usual tests for anemia, there’s a more sensitive test for iron deficiency anemia known as ferritin, that is very relevant in Hashimoto’s and hair loss. You have low iron?

Health and Personal Care Stores 59

Health and Personal Care Stores HIV Treatment and Prevention Agents Insurance Immunization 59

ISPE

MAY 9, 2023

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

AUGUST 30, 2022

With ever-increasing supply chain challenges, raw material shortages have become a point of discussion. In this article, the term “raw material” refers to a material used in the manufacturing and packaging of a drug substance (DS) or a drug product (DP). Burke, PhD. 1 September 2022.

Documentation 52

Documentation FDA Packaging Communication 52

ISPE

MARCH 6, 2023

Challenges for Net Zero Carbon Pharmaceutical Manufacturing Trudy Patterson Mon, 03/06/2023 - 12:40 Features March / April 2023 Challenges for Net Zero Carbon Pharmaceutical Manufacturing Keith M. 1 Intergovernmental Panel on Climate Change (IPCC). C global warming scenario.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

MARCH 29, 2023

The authors propose using Module 2.3 3 1 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. The authors propose using Module 2.3 3 1 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Brown Megan E. McMahon Timothy J.N.

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 29, 2023

The authors propose using Module 2.3 3 1 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. The authors propose using Module 2.3 3 1 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Brown Megan E. McMahon Timothy J.N.

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

AUGUST 29, 2022

Streamlining Postapproval Submissions Using ICH Q12 & SCDM. Streamlining Postapproval Submissions Using ICH Q12 & SCDM. Postapproval change management of pharmaceuticals is an essential part of life-cycle management but is associated with regulatory challenges. Trudy Patterson. Mon, 08/29/2022 - 15:46. September / October 2022.

Documentation 52

Documentation FDA Communication Packaging 52

ISPE

MARCH 7, 2023

1 , 2 The effect to the pharmaceutical industry spans its end-to-end activities, including the residual impact of used and unused medicines on the environment. Scope and Scale of Corporate Ambition Company boards have a duty of service to their shareholders to proactively identify and address key risks impacting their organization.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

JANUARY 8, 2023

However, this comes with an ever-increasing complexity of the algorithms used, rendering such systems more difficult to explain. Current regulatory initiatives also hint at interest in xAI, such as the European Union 3 , 4 and the US Food and Drug Administration guidance 5 addressing concepts of trustworthy AI and human-machine interaction.

Communication 52

Communication Documentation FDA 52

ISPE

MAY 9, 2023

Research Triangle: Building a Foundation for Pharmaceutical and Biotechnology Excellence Trudy Patterson Tue, 05/09/2023 - 09:34 Features May / June 2023 Research Triangle: Building a Foundation for Pharmaceutical and Biotechnology Excellence Scott Fotheringham, PhD 1 May 2023 North Carolina’s Research Triangle is the largest of its kind in the US.

Vaccines 94

Vaccines Pharmaceutical Companies Pharmaceutical Companies Medical Schools 94

The Thyroid Pharmacist

AUGUST 26, 2022

Testing for carnitine deficiency. Eating meat is the primary means for us to take in carnitine through our diet. 6-8) It is often used in supplements intended for athletic performance improvements, optimal fat burning, and muscle recovery. Read on to discover: Why our bodies need carnitine. How carnitine deficiencies occur.

Immunization 81

Immunization Chemotherapy Insurance Dosage 81

ISPE

JANUARY 10, 2023

Both the development of COVID-19 vaccines and monoclonal antibody therapies and supply chain shortages related to the pandemic have affected sup-ply of the essential filters and chromatography resins used in the manufacture of biological products.

Packaging 52

Packaging FDA Communication Vaccines 52

ISPE

OCTOBER 1, 2022

Building Reliability into Bioprocessing – How Component Testing Improves Consistent Performance. Building Reliability into Bioprocessing – How Component Testing Improves Consistent Performance. Trudy Patterson. Sat, 10/01/2022 - 06:00. White Paper — Sponsored Content. 1 October 2022. Company Type. Company Type. State/Province.

Communication 52

Communication 52

ISPE

MARCH 15, 2023

While the term sustainability encompasses a wide scope of goals, in examining manufacturing environmental sustainability we address reducing environmental burdens and progressing to more circular economies throughout the product and manufacturing process life cycle. 7 An integrative (vs. 7 An integrative (vs.

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

Pharmaceutical Technology

MAY 4, 2023

Researchers at IHB will study human biology and speed up the adoption of human model systems in pharmaceutical R&D in addition to clinical practice. Researchers at IHB will study human biology and speed up the adoption of human model systems in pharmaceutical R&D in addition to clinical practice.

Communication 128

Communication 128